Concepedia

James W. Papatzimas

JW

7

Publications

413

Citations

7

H-Index

2016

Active since

Affiliations

University of Calgary(Current)

Novartis (United States)

University of California, Berkeley

Innovative Genomics Institute

James W. Papatzimas is an author at University of Calgary specializing in medicine, drug discovery, and chemistry.

ORCID

Top concepts

Publications per year

2016–2024

7

Publications

7

Rational Chemical Design of Molecular Glue Degraders

Ethan S. Toriki, James W. Papatzimas, Kaila Nishikawa et al. · ACS Central Science · 2023 · 159 citations · Full text

, , +21

From Inhibition to Degradation: Targeting the Antiapoptotic Protein Myeloid Cell Leukemia 1 (MCL1)

James W. Papatzimas, Evgueni Gorobets, Ranjan Maity et al. · Journal of Medicinal Chemistry · 2019 · 95 citations · Full text

DCAF16-Based Covalent Handle for the Rational Design of Monovalent Degraders

Melissa Lim, Thang Do Cong, Lauren M. Orr et al. · ACS Central Science · 2024 · 74 citations · Full text

Thiaporphyrin-mediated photocatalysis using red light

JinGyu Lee, James W. Papatzimas, Ashley D. Bromby et al. · RSC Advances · 2016 · 38 citations · Full text

, , +10

ADAM protease inhibition overcomes resistance of breast cancer stem-like cells to γδ T cell immunotherapy

Indrani Dutta, Dylan Z. Dieters‐Castator, James W. Papatzimas et al. · Cancer Letters · 2020 · 24 citations · Full text

, , +18

Rows per page

1–5 of 7